Blocker Corp.

CV Therapeutics Regains Full Ranexa Rights From Innovex.
BIOWORLD Today; 11/4/2009; 1310 words; ...Research Triangle Park, N.C.-based Quintiles Transnational Corp., warrants for 200,000 shares at a price to be disclosed...pressure and congestive heart failure, and Corgard, a beta blocker for angina and high blood pressure. As for Ranexa, the FDA...

National Semiconductor Introduces Wireless Basestation IF Sampling Receiver Subsystem.
Electronics Newsweekly; 11/4/2009; 950 words; National Semiconductor Corp. (NYSE:NSM) announced the...In the presence of a strong blocker, with the DVGA gain set at 12 dB and blocker level kept at 1.6 dBm input...Keywords: National Semiconductor Corp., Electronics, Semiconductor...

Europe Approves Amgen's Pair: Aranesp, Neulasta In Oncology.
BIOWORLD Today; 11/4/2009; 1048 words; ...comment, but Leah Rush Cann, senior vice president at Wachovia Corp. in New York, said in a research note that the approvals in...methotrexate alone. The FDA approved Kineret, an interleukin-1 blocker, in November. (See BioWorld Today, Nov. 15, 2001.)

Roche Licenses Rights To IL-15 Preclinical Program From Cardion.
BIOWORLD Today; 11/4/2009; 1507 words; ...called CRB-15, a human interleukin-15 cytokine receptor blocker, from Cardion AG. In addition to an undisclosed up-front...by Genentech Inc. and San Diego-based IDEC Pharmaceuticals Corp., while Roche markets it in the rest of the world except Japan...

Fourth Approval For Enbrel: Amgen Adds Spinal Arthritis.
BIOWORLD Today; 11/4/2009; 859 words; ...with Seattle-based Immunex Corp., Enbrel has been approved...July 9, 2003.) Other TNF blockers under development in psoriasis...player in AS. Schering-Plough Corp., of Kenilworth, N.J...analyst with SG Cowen Securities Corp. in New York, predicted sales...